at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed
David M. Tanen
Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
June 20, 2025, 7:59 PM ET
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed
Elena Ridloff
Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
June 20, 2025, 7:59 PM ET
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed
Deborah Knobelman
Other Named Officer
Kronos Bio, Inc.
Effective
2025-06-20
Filed
June 20, 2025, 7:59 PM ET
Dr. Deborah Knobelman resigned from her position as an officer of the Company.
Departed
Roshawn Blunt
Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
June 20, 2025, 7:59 PM ET
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Appointed
Kevin Tang
Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
June 20, 2025, 7:59 PM ET
The sole director of Merger Sub immediately prior to the Effective Time was Kevin Tang.
Departed
Arie Belldegrun
Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
June 20, 2025, 7:59 PM ET
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
On June 16, 2025, in conversations with representatives of the Board of Directors (the “Board”) of Quantum Computing Inc. (the “Company”) Mr. Christopher Boehmler indicated that he would step down as the Company’s Chief Financial Officer (the “CFO Retirement”) effective June 19, 2025
On June 20, 2025, the Board of Directors of Society Pass Incorporated (the “Company”) accepted the resignation of Mr. Howie Ng Kar How (“Mr. Ng”) as the Group Chief Technology Officer (“CTO”).
and Kate Hogan, the current Chief Operating Officer of the Americas, will succeed Mr. Walsh as global Chief Operating Officer, in each case effective September 1, 2025.
Richard MacPherson, President, Chief Executive Officer and a director of the Company, has been appointed Chairman of the Board on an interim basis, to be effective July 1, 2025.
On June 18, 2025, Peter Gianulis was appointed as a director of Gold Resource Corporation (the “ Company ”), effective as of that date.
Departed
Jeff LeBlanc
Independent Director
Cactus Acquisition Corp. 1 Ltd
Effective
2025-06-18
Filed
June 20, 2025, 7:59 PM ET
On 18 June 2025, Jeff LeBlanc, an independent director of Cactus Acquisition Corp. 1 Limited (the “Company”), notified the Company that he has resigned from the Company’s Board of Directors (the “Board”), effective immediately.
announcing that Manuel Chavez, III, the Company’s Chief Executive Officer, will transition from Chief Executive Officer to Executive Chairman of the Board of Directors (the “ Board ”), effective August 1, 2025
the Company announced that its Board appointed Stephanie Hogue, the Company’s President, as Chief Executive Officer effective as of the Effective Date.
On June 17, 2025, Mike Dickerson, the Chief Financial Officer of Twin Vee PowerCats Co. (the “Company”), notified the Company of his decision to resign, effective September 14, 2025, from his position as the Company’s Chief Financial Officer.
On June 16, 2025, Ardent Health, Inc. (the “Company”) and David Schultz determined that Mr. Schultz would no longer serve as President, Hospital Operations and would depart the Company effective immediately.
the majority shareholder Lawrence Garcia, followed Section 3.6 of the bylaws, Resignations and Removals of Directors, appointed Wilhelm Cashen and Terry Slatic, as board members.
the majority shareholder Lawrence Garcia of AmeriGuard Security Services, Inc., followed Section 3.6 of the bylaws, Resignations and Removals of Directors, removed Douglas Anderson and Russel Honore as board members.
the Board of Directors appointed Lawrence Garcia, a director of the Board and Board Chairman as Chief Executive Officer of the Company to assume such executive responsibilities, effective immediately.
the majority shareholder Lawrence Garcia, followed Section 3.6 of the bylaws, Resignations and Removals of Directors, appointed Wilhelm Cashen and Terry Slatic, as board members.
the majority shareholder Lawrence Garcia of AmeriGuard Security Services, Inc., followed Section 3.6 of the bylaws, Resignations and Removals of Directors, removed Douglas Anderson and Russel Honore as board members.
the Board of Directors of AmeriGuard Security Services, Inc., removed Douglas Anderson, from the position of Interim Chief Executive Officer of the Company, effective immediately.
Departed
Rebecca A. Hoyt
senior vice president, Chief Accounting Officer, and Controller
On June 17, 2025, Rebecca A. Hoyt, senior vice president, Chief Accounting Officer, and Controller, informed APA Corporation (the “Company”) of her intention to retire from the Company.
Appointed
Melissa Washington
Senior Vice President, Government, Regulatory, and External Affairs
COMMONWEALTH EDISON Co
Effective
2025-09-01
Filed
June 18, 2025, 7:59 PM ET
Effective September 1, 2025, Melissa Washington, currently ComEd’s Senior Vice President, Customer Operations and Strategic Initiatives, will assume the role of Senior Vice President, Government, Regulatory, and External Affairs.
Role change
Lewis Binswanger
Special Advisor to ComEd CEO
COMMONWEALTH EDISON Co
Effective
2025-09-01
Successor
Melissa Washington
Filed
June 18, 2025, 7:59 PM ET
Mr. Binswanger will continue to serve as Senior Vice President, Government, Regulatory, and External Affairs until September 1, 2025, at which point he will assume the role of Special Advisor to ComEd CEO.
Departed
Lewis Binswanger
Senior Vice President, Government, Regulatory, and External Affairs
COMMONWEALTH EDISON Co
Effective
2026-01-01
Filed
June 18, 2025, 7:59 PM ET
On June 12, 2025, Commonwealth Edison Company (ComEd) announced that Lewis Binswanger, Senior Vice President, Government, Regulatory, and External Affairs, will depart ComEd effective January 1, 2026.
On June 17, 2025, Fran Horowitz informed Conagra Brands, Inc. (the “Company”) that she has decided not to stand for reelection to the Board of Directors at the Company’s 2025 Annual Meeting of Shareholders to be held in September.
On June 13, 2025, Cathleen Benko notified NIKE, Inc. (the “Company”) of her decision to retire as a member of the Board of Directors of the Company (the “Board”) effective as of the Company’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”).
On June 18, 2025, Ciena Corporation (the “Company”) announced the appointment of Marc D. Graff as Senior Vice President and Chief Financial Officer and that the Board of Directors of the Company (the “Board”) has designated Mr. Graff as the Company’s principal financial officer and principal accounting officer, effective, in each case, as of August 1, 2025 (the “Effective Date”).
On June 16, 2025, Carol Ashe notified the Board of Directors (the “Board”) of Aptose Biosciences Inc. (the “Company”) of her intention to resign from her role as a member of the Board effective immediately.
On June 16, 2025, the Board of Directors (the “Board”) of BJ’s Restaurants, Inc. (the “Company”) named Lyle D. Tick, the Company’s Chief Executive Officer and President, as a member of the Board.
In addition, on June 16, 2025, Gregory A. Trojan, the Company’s former Chief Executive Officer, informed the Board that he would be retiring from the Board effective September 16, 2025.
Role change
Pushkal Garg
Executive Vice President, Chief Research and Development Officer
the Committee approved (i) the appointment of Pushkal Garg, M.D., the Company’s current Chief Medical Officer, Executive Vice President, Development and Medical Affairs, to the position of Executive Vice President, Chief Research and Development Officer
The Board of Directors (the “Board”) of Climb Bio, Inc. (the “Company”) appointed Cindy Driscoll as Senior Vice President, Finance of the Company and designated her as the Company’s principal financial officer and principal accounting officer, effective as of June 17, 2025
In connection with Hugues Meyrath’s appointment as President and Chief Executive Officer of Quantum Corporation (the “Company”), on June 12, 2025, Mr. Meyrath entered into an offer letter (the “Offer Letter”) with the Company providing for the following terms:
On June 18, 2025, the Company announced that in connection with the workforce reduction, the employment of Carol D. Karp, the Company’s Chief Regulatory Officer, and David A. Ford, the Company’s Chief People Officer, will terminate effective August 1, 2025.
On June 18, 2025, the Company announced that in connection with the workforce reduction, the employment of Carol D. Karp, the Company’s Chief Regulatory Officer, and David A. Ford, the Company’s Chief People Officer, will terminate effective August 1, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.